Form 4: Globe Life Exec Sells Shares After Option Exercise
Insider Transaction Report
Globe Life Inc. EVP and Chief Administrative Officer Dolores L. Skarjune sold 4,500 shares of common stock after exercising employee stock options.
Summary
- Dolores L. Skarjune, Executive Vice President and Chief Administrative Officer of Globe Life Inc., engaged in a series of transactions involving company stock.
- On September 12, 2025, Skarjune exercised employee stock options to acquire 2,100 shares of common stock at an exercise price of $82.56 per share.
- Concurrently, she exercised additional employee stock options to acquire 2,400 shares of common stock at an exercise price of $98.32 per share.
- Immediately following these exercises, Skarjune sold all 4,500 shares of common stock acquired at a price of $142.52 per share.
- After these reported transactions, Skarjune directly holds 9,417 shares of Globe Life Inc. common stock.
- Additionally, she indirectly holds 2,701.527 shares through a 401(K) Plan.
- Skarjune retains beneficial ownership of 2,475 employee stock options with an exercise price of $98.32, which are exercisable from February 24, 2024, and expire on February 24, 2028.
Sentiment
Score: 5
Explanation: The filing reports a routine insider transaction involving option exercise and sale, which is neutral in terms of company-specific sentiment. It reflects executive compensation activity rather than operational performance.
Positives
- The executive exercised options that were significantly in-the-money, indicating a profitable transaction for her.
- The sale price of $142.52 per share is substantially higher than both exercise prices ($82.56 and $98.32), demonstrating the value appreciation of the company's stock.
Negatives
- The executive sold all shares acquired from the option exercises, rather than retaining them to increase her direct equity stake in the company.
Future Outlook
NA
Industry Context
This Form 4 filing details a routine insider transaction related to executive compensation, which is common across all industries. It does not provide specific insights into broader industry trends or competitive landscape for Globe Life Inc.
Stakeholder Impact
- Shareholders: The transaction is a routine part of executive compensation and is unlikely to have a significant direct impact on the company's share price or long-term value. It provides transparency into insider holdings and transactions.
- Employees: No direct impact on employees is indicated by this filing.
Key Dates
| Date | Description |
|---|---|
| 02/28/2022 | Date exercisable for 2,100 employee stock options. |
| 02/24/2024 | Date exercisable for 2,400 employee stock options. |
| 09/12/2025 | Date of employee stock option exercises and subsequent sale of common stock. |
| 09/15/2025 | Signature date of the reporting person on the Form 4 filing. |
| 02/28/2026 | Expiration date for the 2,100 employee stock options that were exercised. |
| 02/24/2028 | Expiration date for the remaining 2,475 employee stock options. |
Keywords
Globe Life Inc., GL, insider trading, Form 4, stock options, executive compensation, share sale, common stock, Dolores L. Skarjune
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.